Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GMED - GenoMed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: jmhollen who wrote (154)	7/23/2004 8:07:44 PM
From: Tadsamillionaire	Read Replies (1) \| Respond to of 347

Genomics will be to the 21st Century what infectious disease was to the 20th Century for public health. It has the potential to change our thinking. Genomics should be considered in every facet of public health: infectious disease, chronic disease, occupational health, and environmental health, in addition to maternal and child health." S. Gerard, M. Hayes, and M.A. Rothstein J Law Med Ethics; 2002 Fall; 30 (3 Suppl):173-176 In April 2003, the Human Genome Project was pronounced complete. Now, as we officially enter the genomics era, what will this mean for public health? Will genomic information lead to new opportunities for preventing disease or will it provide a new mechanism for excluding people from insurance or employment? Will genomics make any real difference to the practice of public health? The intent of this Public Health Perspective is to collect some of the relevant articles, stories and on-line materials that look at where we’ve been and attempt to project where we might be in the future. cdc.gov